TXP Medical is a physician-founded health-tech company (est. 2017, Tokyo) that operates Japan’s largest hospital-EMR real-world database by patient count — 38.5 million patients across 53 major hospitals as of March 2026. The company has supported 40+ pharmaceutical clients including the majority of Japan’s top-20 pharma companies.Data – Built on the back of NEXT Stage ER, a clinical platform deployed in 100+ hospitals (~40% of Japan’s university hospitals), TXP Medical’s DWH offers:
- 38.5 million patients across over 50 major hospitals
- 800-bed-class institutional hospitals — university hospitals, tertiary emergency centers, and regional flagships
- All clinical departments — not limited to a single specialty
- ~900 standardized lab/vital-sign items standardized and structured across institutions
- Full-text clinical notes, DPC claims, departmental reports (pathology, imaging, genetics), and structured acute-care data with 15+ year tracking
Use Case Examples
- Medical Affairs — Treatment-pattern analyses, unmet-needs studies, real-world evidence generation, and DX-enabled prospective research with automated data capture with TXP data warehouse
- Market Access — Health-economics evaluations and cost-effectiveness studies using linked EMR + DPC data
- Marketing — Patient journey mapping, rare-disease awareness programs via real-time clinical alerts at the point of care
- Development — Clinical trial feasibility assessment, site selection, and automated patient screening for recruitment
Research Capability
- In-house team of 30+ physician members provides end-to-end support from study design through publication — 91 PubMed-indexed original papers (2020–2025).
